目的：评价阻塞性睡眠呼吸暂停低通气综合征（obstructive sleep apnea hypopnea syndrome, OSAHS）患者持续正压通气（continuous positive airway pressure, CPAP）治疗副作用自评量表的信度与效度。方法根据相关文献和临床工作自制CPAP治疗副作用自评量表，采用内部一致性分析和重测信度法检测量表的信度；采用专家评议，选用副反应量表(Treatment Emergent Symptom Scale, TESS）、汉密尔顿焦虑量表（Hamilton Anxiety Scale, HAMA）、健康调查简表（the MOS 36-item Short-form Health Survey, SF-36）作为效标并结合因子分析法测量量表效度。结果量表内部一致性信度Cronbach’sα系数为0.825，重测信度为0.687；内容效度指数为0.870，量表与TESS、HAMA、SF-36显著相关（P<0.01），累积方差贡献率为77.271%，条目在相应因子上的负荷>0.4。结论 CPAP治疗副作用自评量表具有较好的信度与效度，可应用于OSAHS患者CPAP治疗副作用以及其对依从性影响的评估。%Objective To evaluate the reliability and validity of self-rating adverse reaction of continuous positive airway pressure (CPAP) scale among patients with obstructive sleep apnea hypopnea syndrome (OSAHS). Methods A self-rating adverse reaction of CPAP scale was developed based on literatures and clinical practice. The reliability of the scale was evaluated by internal consistency and test-retest reliability. Through expert review, taking Treatment Emergent Symptom Scale (TESS), Hamilton Anxiety Scale (HAMA) and the MOS 36-item Short-form Health Survey (SF-36) as criterion, the validity of the scale was evaluated with factor analysis. Results Cronbach’sαcoefficient was 0.825, ICC 0.687 and CVI 0.870. The scale was significantly related with TESS, HAMA and SF-36 (P<0.01) with the accumulative variance contribution rate of 77.271% and the load of every item on corresponding factor was higher than 0.4. Conclusion The self-rating adverse reaction of CPAP scale among OSAHS patients is with good reliability and validity and could be applied in the evaluation of adverse reaction of CPAP among OSAHS patients and its influence on patients’ compliance.
展开▼
